tiprankstipranks
Advertisement
Advertisement
PremiumCompany AnnouncementsXORTX files Q1 2026 unaudited results showing lower cash and equity
2M ago
Xortx Therapeutics 2.66M share Spot Secondary priced at $1.88
Premium
The Fly
Xortx Therapeutics 2.66M share Spot Secondary priced at $1.88
3M ago
Premium
Company Announcements
XORTX Therapeutics Prices US$5 Million Public Offering to Fund Late-Stage Kidney and Gout Pipeline
3M ago
PremiumCompany AnnouncementsXORTX Closes US$3 Million Deal for Vectus Kidney Anti-Fibrotic Program
4M ago
Xyratex Ltd. trading halted, news pending
Premium
The Fly
Xyratex Ltd. trading halted, news pending
4M ago
Premium
Company Announcements
XORTX Therapeutics Secures Exchange Approvals for 1-for-5 Share Consolidation Effective April 6
4M ago
PremiumCompany AnnouncementsXORTX Shareholders Approve Reverse Split to Preserve Nasdaq Listing
4M ago
Premium
Company Announcements
XORTX Ties Board Shake-Up to Financing Ahead of March 24 Shareholder Vote
5M ago
Premium
Company Announcements
XORTX Reshapes Board to Meet Conditions for Planned Financing
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100